CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Practice Management

Psychiatric Times.
 

Spitzer Recants: Why Can’t the APA Admit Mistakes and Correct Them?

By Allen Frances, MD | May 30, 2012

Ben Carey’s front-page story in The New York Times movingly recounts Bob Spitzer’s apology for an ill-advised study he conducted more than a decade ago.

The background is dramatic. Spitzer had been a hero to the gay and lesbian community because he was the person most responsible for removing homosexuality from DSM-II. Lifting the cloud of mental disorder from sexual choice was a big step in the civil rights movement that only now is bringing full equality. I once attended an award dinner honoring Bob for his contributions to the gay/lesbian cause. I never saw a group more appreciative or a recipient so proud.

(MORE: Major University Establishes New LGBT Health Center)

How surprising then that Spitzer would later publish a methodologically flawed paper suggesting that psychotherapy might have some value in changing sexual orientation. Bob had serious misgivings almost immediately when fundamentalists exploited the paper to pursue their anachronistic agenda. He decided recently to make a very public apology. “I believe I owe the gay community an apology for my study making unproven claims of the efficacy of reparative therapy. I also apologize to any gay person who wasted time and energy undergoing some form of reparative therapy because they believed that I had proven that reparative therapy works with some ‘highly motivated’ individuals.”

Let’s compare Bob’s forthrightness to the stonewalling that has characterized every step in the development of DSM-5. The American Psychiatric Association has a lot to apologize for—but instead maintains a defensive posture that prevents insight and self-correction.

Bob was the first to point out the absurdity of the DSM-5 confidentiality agreements and to predict the poor results that would come from the resulting closed process. Each of his dire predictions has turned out to be right on target. DSM-5 badly missed every one of its deadlines—then with time running short, it quietly cancelled its quality control step because publishing profits trumped the public trust of producing a safe product. No apology for that.

When its field trial results were unacceptably low by historical standards, DSM-5 lowered its standards rather than working to improve its product to meet them. Again no apology.

DSM-5 persists in offering proposals that would inappropriately inflict the label “mental disorder” on millions of people now considered “normal.” These suggestions are unsupported by science and are strongly opposed by 51 mental health associations—but the APA continues to refuse demands for independent external review.

The DSM-5 enterprise has reduced the credibility of psychiatry and the stature of the APA. It may well have forfeited the APA’s right to continue as custodian of the DSM franchise. Yes, indeed, the APA has a lot to apologize for and DSM-5 has a long way to go before it will be safe and scientifically sound.

There are two small rays of hope. First, DSM-5 has belatedly dropped its worst proposal—psychosis risk—opening the door to the possibility that it is finally ready to make much needed concessions.

Second, the APA leadership changed hands at the recent annual meeting. Perhaps the new leaders will finally bring responsible governance to what has heretofore been the almost fatally flawed DSM-5 process.

The smart play for them now is also the only right thing to do. The APA should, like Bob, come clean that many mistakes have been made and that it will take the time and make the effort to correct them. The APA should cancel the arbitrary DSM-5 publication date and continue to work on DSM-5 until it can produce a quality document. It should drop the proposals that have drawn such widespread opposition or open them up to independent scientific review. Someone who can write clean and consistent criteria sets should be recruited and, after the badly needed editing is completed, previously poorly performing criteria sets need to be retested.

Unless it delays and reforms DSM-5, the new leadership will be left holding the bag—having to defend the truly indefensible when a fourth-rate DSM-5 is published next May. The new leaders are not responsible for this mess and don’t deserve to be the butt of the harsh criticism that will follow. But if they don’t fix DSM-5, they will own it and be tainted by it.

The APA should clean the DSM-5 house now, before it’s too late. Were he alive today, that’s what Mel Sabshin, its long-term and much revered leader, would certainly recommend.

And Bob Spitzer has shown the way. A clear parallel can be drawn between Bob’s openly apologizing and withdrawing his paper and the need for the APA to apologize and to withdraw its untenable proposals, end its closed process, and drop its adherence to unrealistic timelines.

If a legendary figure like Bob can correct his mistakes, surely the APA can do the same—for the sake of protecting our patients and keeping the mental health field united.

There is always regret for having made errors along the way, but the far greater shame is in pressing forward when your own results reveal them. Inertia is one of the most powerful forces in nature—it takes real courage to oppose it. If the APA changes gears, none of us is going to say, “I told you so!” We’re going to applaud and feel proud that the APA is finally on the right track. As with Bob Spitzer, sometimes the greatest honor is to admit mistakes and do the very best we can to correct them.

If it fails to reform DSM-5 now, the APA leadership will have much more to apologize for in the future—to its members, to our colleagues, and of course most important to our patients.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

More by Allen Frances, MD

Spitzer Recants: Why Can’t the APA Admit Mistakes and Correct Them?

Wonderful News: DSM-5 Finally Begins Its Belated And Necessary Retreat

Definitive Study Rejects the Diagnosis of “Psychosis Risk” and Finds No Treatment Benefit

Internet Addiction—The Next New Fad Diagnosis

Fighting the Wrong War on Drugs

The Epidemic of Military Suicide

The Military Can Do More To Prevent Suicides

DSM-5 Is A Guide, Not A Bible—Simply Ignore Its 10 Worst Changes

Mislabeling Medical Illness As Mental Disorder

DSM-5 Confirms That Rape Is Crime, Not Mental Disorder

Yet Another Way the Medically Ill Will Be Misdiagnosed as Mentally Disordered

Prison or Treatment for the Mentally Ill

Giftedness Should Not Be Confused With Mental Disorder

More like this

Sex Orientation Change Therapy: Back in the Headlines

LGBT: Tips for Trans-Inclusion in Mental Health

If I am not for myself: The Trials and the Triumphs of the Transgendered

Spitzer Recants: Why Can’t the APA Admit Mistakes and Correct Them?

The Transgender Conundrum

Major University Establishes New LGBT Health Center






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Conflicts of Interest in Medicine: What About Ties to Payers?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Practice Management
Evidence on Practice Management
Guidelines on Practice Management
Patient Education on Practice Management
Clinical Trials on Practice Management
Practical Articles on Practice Management
Research and Reviews on Practice Management
All "Practice Management" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy